Bodycote (LON:BOY – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Berenberg Bank in a research report issued on Thursday, MarketBeat reports. They currently have a GBX 900 target price on the stock. Berenberg Bank’s price target suggests a potential downside of 1.59% from the company’s previous close.
A number of other brokerages also recently weighed in on BOY. Jefferies Financial Group reiterated a “buy” rating and set a GBX 900 price target on shares of Bodycote in a report on Wednesday, July 29th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 960 price objective on shares of Bodycote in a research report on Wednesday, July 29th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a GBX 750 target price on shares of Bodycote in a research note on Wednesday, July 29th. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Bodycote currently has a consensus rating of “Moderate Buy” and an average price target of GBX 875.83.
View Our Latest Stock Report on BOY
Bodycote Price Performance
Bodycote (LON:BOY – Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported GBX 18.10 EPS for the quarter. Bodycote had a net margin of 7.87% and a return on equity of 9.30%. On average, analysts forecast that Bodycote will post 54.0540541 earnings per share for the current year.
Bodycote Company Profile
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Recommended Stories
- Five stocks we like better than Bodycote
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.
